# CAR T Cells in Mesothelin-Expressing Breast Cancer

> **NCT05623488** · PHASE1 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 2 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** huCART-meso cells
- **DEVICE:** Mesothelin Expression Testing

## Key facts

- **NCT ID:** NCT05623488
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-06
- **Primary completion:** 2025-04-07
- **Final completion:** 2025-04-07
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Feasibility Concerns
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05623488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05623488, "CAR T Cells in Mesothelin-Expressing Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05623488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*